HIV Clinical Trials

101 studies are recruiting for hiv in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

  1. Small Trial of Alendronate Impact on the Reservoir of HIV

    This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers k…

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    University of California, San Francisco HIV/AIDS (Site ID: 801), San Francisco, California
    Locations
    5 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)
  2. Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual Men

    Older gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. B2B is a peer-deliv…

    Stage
    Not phased
    Ages
    50 and older
    Site
    Fenway Health, Boston, Massachusetts
    Run by
    Fenway Community Health
  3. High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV

    This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome vascular and cognit…

    Stage
    Not phased
    Ages
    50 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  4. Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV

    The goal of this clinical trial is to examine 3 interventions designed to increase physical activity in older adults with HIV. We will examine 3 potential components of an intervention package: physical activity coaching, cognitive behavioral therapy targeted toward common barriers to physical acti…

    Stage
    Not phased
    Ages
    50 and older
    Site
    Hennepin Healthcare Research Institute, Minneapolis, Minnesota
    Locations
    2 in total
    Run by
    Butler Hospital
  5. Bringing Medicines for HIV Prevention to a Family Planning Clinic

    The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients fin…

    Stage
    Not phased
    Ages
    16 and older
    Site
    Women and Infants Hospital of Rhode Island, Providence, Rhode Island
    Run by
    Women and Infants Hospital of Rhode Island
  6. Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

    This is a phase 1, multicenter, open-label, dose escalation, first-in-human (FIH) trial to evaluate the safety and immunogenicity of DV201P-RNA and DV202B1-RNA, immunogens designed to induce HIV-1 envelope (Env) V2 apex-specific broadly neutralizing antibodies (V2 apex bnAbs). Both vaccines consist…

    Stage
    Phase 1
    Ages
    18 to 55
    Site
    The Ponce de Leon Center CRS (Site ID 5802), Atlanta, Georgia
    Locations
    7 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)
  7. BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

    The goal of this clinical trial is to compare two interventions - Basic Income Guarantee (BIG) + Treatment as Usual and Treatment as Usual among individuals living with HIV who have experienced financial hardships. The main question it aims to answer is: Compared with the Treatment as Usual group, …

    Stage
    Not phased
    Ages
    18 to 35
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  8. Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

    This is a phase 2, open-label study to assess the immunogenicity of the 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil9) in people born male with current or past exposure to androgen blockers or estrogen (BM-EABE). Investigators will enroll BM-EABE with HIV and HIV negative contr…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    RIIS Clinic at Baltimore Safe Haven, Baltimore, Maryland
    Locations
    2 in total
    Run by
    University of Maryland, Baltimore
  9. Human Immunodeficiency Virus (HIV) Food Insecurities

    The objectives of this study are to better understand how FI (food insecurities) contributes to the development of cardiometabolic comorbidities among PWH (People with HIV) and to test a novel bilingual FI intervention designed to reduce these comorbidities among food insecure PWH. The PI and staff…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Wake Forest Health Sciences, Winston-Salem, North Carolina
    Run by
    Wake Forest University Health Sciences
  10. Case Management Dyad

    The overall goal of this study is to test whether dyadic and focused case management will (1) improve financial wellbeing, (2) improve access to food, (3) increase linkage and retention rates for individuals living with HIV or those taking PrEP (PrEP persistence), and (4) increase the proportion of…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago, Chicago, Illinois
    Run by
    University of Chicago
  11. Alcohol and "Heat of the Moment" Sexual Decision Making

    HIV transmission remains a significant public health concern, especially among men who have sex with men (MSM). Condomless anal intercourse (CAI) continues to be the major route of transmission for MSM. Thus, to reduce the incidence of HIV, it is critical to identify how contextual risk factors inf…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Boston University Department of Psychological and Brain Sciences, Boston, Massachusetts
    Run by
    Boston University Charles River Campus
  12. Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

    This is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people. This study will also evaluate the impact of endogenous and therapeutic hormones on CAB-LA pharmacology. The investigators will also evaluate if participants experience any medical pro…

    Stage
    Phase 1
    Ages
    19 and older
    Site
    Johns Hopkins School of Medicine, Drug Development Unit, Baltimore, Maryland
    Run by
    Johns Hopkins University
  13. Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain

    The purpose of this research study is to test whether Brief Behavioral Treatment for Insomnia (BBTI) delivered over the phone or Brief Mindfulness Training (BMT) delivered over the phone is better able to improve the symptoms of insomnia, reduce chronic pain, and slow the pace of biological aging i…

    Stage
    Not phased
    Ages
    25 to 65
    Site
    Washington University School of Medicine, St Louis, Missouri
    Run by
    Washington University School of Medicine
  14. The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV

    To elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study team proposes a tight…

    Stage
    Not phased
    Ages
    18 to 59
    Site
    University of Miami, Miami, Florida
    Run by
    University of Miami
  15. Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

    Despite availability of evidence-based alcohol reduction interventions (EBI), unhealthy alcohol use remains a barrier to HIV medication adherence, viral suppression and retention in HIV care and consequently HIV treatment as prevention (TASP). Guided by complementary implementation and evaluation f…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of California, San Diego, San Diego, California
    Locations
    3 in total
    Run by
    Johns Hopkins University
  16. A Study to Improve Skeletal Muscle in Veterans With HIV

    The Department of Veterans Affairs is the largest single provider of medical care to people with HIV in the United States. The condition of excess lipid within and around muscle, termed myosteatosis, predisposes Veterans to physical function decline, frailty, disability, and cardiometabolic disease…

    Stage
    Not phased
    Ages
    20 to 80
    Site
    Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville, Tennessee
    Run by
    VA Office of Research and Development
  17. Implementing Depression and Adherence Treatment

    The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are: What proportion of patients start an evidence-based treatment fo…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Miami, Miami, Florida
    Locations
    3 in total
    Run by
    University of Miami
  18. Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

    People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER interve…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Florida International University, Miami, Florida
    Locations
    2 in total
    Run by
    Boston University
  19. Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

    This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    18 in total
    Run by
    Johns Hopkins University
  20. Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

    The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

    Stage
    Not phased
    Ages
    16 to 24
    Site
    University of California, Los Angeles, Los Angeles, California
    Locations
    2 in total
    Run by
    Westat
  21. Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

    The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enh…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    APT Foundation, New Haven, Connecticut
    Run by
    University of Connecticut
  22. RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry

    Justice-involved individuals face disproportionately high rates of stimulant use disorder and HIV, along with disrupted access to HIV treatment and prevention services like ART and PrEP. Contingency management (CM) is the most effective intervention for stimulant use, but its use in justice-involve…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    2 in total
    Run by
    University of Texas Southwestern Medical Center
  23. Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD

    People living with HIV (PLWH) have a higher rate of post-traumatic stress disorder (PTSD) diagnosis than the general population. Comorbid PTSD is also associated with negative HIV-related health outcomes. Unfortunately, little outcome research has examined the usefulness of PTSD treatments for PTSD…

    Stage
    Not phased
    Ages
    18 to 65
    Site
    Albert Einstein College of Medicine, The Bronx, New York
    Run by
    Montefiore Medical Center
  24. Skeletal Muscle Energetics and Fatiguability in Older Individuals

    The investigators are studying whether metabolic abnormalities in calf (leg) muscle in older people with and others without HIV are associated with decreased abilities to exercise.

    Stage
    Not phased
    Ages
    60 to 90
    Site
    Johns Hopkins Hospital, Baltimore, Maryland
    Run by
    Johns Hopkins University
  25. Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

    The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ). This study evaluates a newly validated PrEP decision ai…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Alabama in Birmingham, Birmingham, Alabama
    Locations
    2 in total
    Run by
    Yale University

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.